Article Information
PMID
Published By
Print ISSN
0250-7005
Online ISSN
1791-7530
History
- Received August 27, 2012
- Revision received October 10, 2012
- Accepted October 11, 2012
- Published online December 6, 2012.
Copyright & Usage
Copyright© 2012 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
Author Information
- TOSHIHIRO FUKUSHIMA1⇓,
- TOMOMI SATO1,
- TAKUJI NAKAMURA1,
- HARUKA IWAO1,
- AKIO NAKAJIMA1,
- MIYUKI MIKI1,
- TOMOYUKI SAKAI1,
- TAKAFUMI KAWANAMI1,
- TOSHIOKI SAWAKI1,
- YOSHIMASA FUJITA1,
- MASAO TANAKA1,
- YASUFUMI MASAKI1,
- TOSHIRO OKAZAKI1,
- HIDEO NAKAJIMA2,
- YOSHIHARU MOTOO2 and
- HISANORI UMEHARA1
- 1Department of Hematology and Immunology, Kanazawa Medical University, Ishikawa, Japan
- 2Department of Medical Oncology, Kanazawa Medical University, Ishikawa, Japan
- Correspondence to: Toshihiro Fukushima, MD, Ph.D., Department of Hematology and Immunology, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Ishikawa 920-0293, Japan. Tel: +81 762862211, Fax: +81 762869290, e-mail: tfukus{at}kanazawa-med.ac.jp
Statistics from Altmetric.com
Cited By...
In this issue
Jump to section
Related Articles
Cited By...
- Importance of Compliance With Guidelines for the Prevention of Varicella-Zoster Virus Reactivation in Multiple Myeloma
- Prophylactic Efficacy Against Herpes Zoster and Costs Difference Between Acyclovir and Valaciclovir in Hematological Patients
- Bortezomib-Induced Unfolded Protein Response Increases Oncolytic HSV-1 Replication Resulting in Synergistic Antitumor Effects